Standardization of antiphospholipid antibody assays. Where do we stand?

Lupus

Volumn 21, Issue 7, 2012, Pages 718-721

  Devreese, K M J ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

anti 2 glycoprotein I antibodies; anti cardiolipin antibodies; guidelines; international standard; Lupus anticoagulants; standardization

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; CONFERENCE PAPER; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DILUTED RUSSELL VIPER VENOM TIME TEST; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; IMMUNOASSAY; LABORATORY DIAGNOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; STANDARDIZATION;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION TESTS; HUMANS; REFERENCE STANDARDS;

EID: 84861565981     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312439335     Document Type: Conference Paper

References (26)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4: 295-306
2. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999 ; 42: 1309-11
3. Giannakopoulos B, Krilis SA. How I treat the antiphospholipid syndrome. Blood. 2009 ; 114: 2020-30
4. Devreese K, Hoylaerts MF. Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome. Eur J Haematol. 2009 ; 83: 1-16
5. Wong RC. Consensus guidelines for anticardiolipin antibody testing. Thromb Res. 2004 ; 114: 559-71
6. Reber G, Tincani A, Sanmarco M, de Moerloose P, Boffa MC. Proposals for the measurement of anti-beta2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost. 2004 ; 2: 1860-2
7. Pierangeli SS, Harris EN. A protocol for determination of anticardiolipin antibodies by ELISA. Nat Protoc. 2008 ; 3: 840-8
8. Lakos G, Favaloro EJ, Harris EN, et al. International consensus guidelines on anticardiolipin and anti-beta(2) glycoprotein I testing: A report from the APL task force at the 13th International Congress on Antiphospholipid Antibodies. Arthritis Rheum 2011.
9. Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2009 ; 7: 1737-40
10. Devreese KM. No more mixing tests required for integrated assay systems in the laboratory diagnosis of lupus anticoagulants?. J Thromb Haemost. 2010 ; 8: 1120-2
11. Favaloro EJ, Bonar R, Zebeljan D, Kershaw G, Marsden K. Laboratory investigation of lupus anticoagulants: mixing studies are sometimes required. J Thromb Haemost. 2010 ; 8: 2828-31
12. Tripodi A, Pengo V. More on: laboratory investigation of lupus anticoagulants: mixing studies are sometimes required. J Thromb Haemost. 2011 ; 9: 2126-7
13. Coppens A, Devreese KM. Evaluation of commercial normal pooled plasma used in the laboratory diagnosis of lupus anticoagulants. Thromb Res. 2010 ; 126: 246-9
14. Persijn L, Decavele AS, Schouwers S, Devreese K. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome. Thromb Res. 2011 ; 128: 565-9
15. de Moerloose P, Reber G, Musial J, Arnout J. Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome. J Thromb Haemost. 2010 ;: 1540-6
16. Urbanus RT, de Groot PG. Antiphospholipid antibodies-we are not quite there yet. Blood Rev. 2011 ; 25: 97-106
17. Devreese K, Peerlinck K, Hoylaerts MF. Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants. Blood. 2010 ; 115: 870-8
18. CLSI. Defining, establishing and verifying reference intervals in the clinical laboratory; approved guideline. C28-A3 2008.
19. Devreese KM, Van Hoecke F. Anticardiolipin and anti-beta2glycoprotein-I antibody cut-off values in the diagnosis of antiphospholipid syndrome: more than calculating the in-house 99th percentiles, even for new automated assays. Thromb Res. 2011 ; 128: 598-600
20. Devreese K. The problem of inter-assay variability in antiphospholipid antibody assays persists. J Thromb Haemost. 2011 ; 9 (supplement s2). 167-167
21. Reber G, Tincani A, Sanmarco M, et al. Variability of anti-beta2 glycoprotein I antibodies measurement by commercial assays. Thromb Haemost. 2005 ; 94: 665-72
22. Ichikawa K, Tsutsumi A, Atsumi T, et al. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies. Arthritis Rheum. 1999 ; 42: 2461-70
23. Harris EN, Gharavi AE, Patel SP, Hughes GR. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol. 1987 ; 68: 215-22
24. Dienava-Verdoold I, Boon-Spijker MG, de Groot PG, et al. Patient-derived monoclonal antibodies directed towards beta2 glycoprotein-1 display lupus anticoagulant activity. J Thromb Haemost. 2011 ; 9: 738-47
25. Lieby P, Soley A, Levallois H, et al. The clonal analysis of anticardiolipin antibodies in a single patient with primary antiphospholipid syndrome reveals an extreme antibody heterogeneity. Blood. 2001 ; 97: 3820-8
26. Pierangeli SS, Favaloro EJ, Lakos G, et al. Standards and reference materials for the anticardiolipin and anti-beta(2)glycoprotein I assays: A report of recommendations from the APL Task Force at the 13th International Congress on Antiphospholipid Antibodies. Clin Chim Acta. 2012 ; 413: 358-60